Matthew J. Zimpfer - 17 Feb 2026 Form 4 Insider Report for CNO Financial Group, Inc. (CNO)

Reporting relationship: General Counsel
Issuer ticker: CNO
Reported as of: 17 Feb 2026
Net transaction value: -$1,331,842
SEC form: 4
Accepted by SEC: 18 Feb 2026, 19:36:26 UTC
Prior SEC filing: 12 Feb 2026
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: Heidi M. Krings, Attorney-in-Fact

Key filing fact

Matthew J. Zimpfer filed Form 4 for CNO Financial Group, Inc. (CNO) on 18 Feb 2026.

Key facts

This page summarizes Matthew J. Zimpfer's Form 4 filing for CNO Financial Group, Inc. (CNO).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Feb 2026, 19:36.

Change

Previous filing in this sequence was filed on 12 Feb 2026.
Current net transaction value: -$1,331,842.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001438233 Primary reporting owner

Zimpfer Matthew J.

Relationship: General Counsel
Address: C/O CNO FINANCIAL GROUP, INC., 11299 ILLINOIS STREET, SUITE 200, CARMEL
Signature: Heidi M. Krings, Attorney-in-Fact
Signature date: 18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNO transaction

Common Stock

Options Exercise

Transaction value: $549,888
Shares: +23,570
Change %: +7.7%
Price: $23.33
Shares after: 331,507
Date: 17 Feb 2026
Ownership: Direct

CNO transaction

Common Stock

Sale

Transaction value: $1,017,413
Shares: -23,570
Change %: -7.1%
Price: $43.17
Shares after: 307,937
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F1, F2

CNO transaction

Common Stock

Options Exercise

Transaction value: $590,824
Shares: +33,800
Change %: +11%
Price: $17.48
Shares after: 341,737
Date: 18 Feb 2026
Ownership: Direct

CNO transaction

Common Stock

Sale

Transaction value: $1,455,141
Shares: -33,800
Change %: -9.9%
Price: $43.05
Shares after: 307,937
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNO transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -23,570
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,570
Exercise price: $23.33
Footnotes: F4

CNO transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -33,800
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,800
Exercise price: $17.48
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.

Footnote F2

Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Footnote F3

Reflects the weighted average sale price. Shares were sold at prices ranging from $42.92 per share to $43.28 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Footnote F4

One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021.

Footnote F5

One-half of the stock options vested and became exercisable on February 19, 2021, and one-half vested and became exercisable on February 19, 2022.